Name | Title | Contact Details |
---|---|---|
Anthony Rossomando |
Chief Technology Officer | Profile |
Ophthotech is a biopharmaceutical company specializing in the development of novel therapeutics to treat back of the eye diseases, with a focus on developing innovative therapies for age-related macular degeneration (AMD). Ophthotech`s most advanced product candidate, Fovista® anti-PDGF therapy, is in Phase 3 clinical trials for use in combination with anti-VEGF therapy that represents the current standard of care for the treatment of wet AMD. Ophthotech`s second product candidate, Zimura®, an inhibitor of complement factor C5, is being developed for the treatment of geographic atrophy, a form of dry AMD.
Fresh Tracks Therapeutics is a clinical-stage pharmaceutical company focused on transforming patient lives through the development of innovative and ground-breaking prescription therapeutics.
Control and Power Systems Inc is a Fairfield, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Ferring Research Institute is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Veranova is a global leader in process development and manufacturing of active pharmaceutical ingredients (APIs), focused on specialty niches with expertise in highly regulated and complex chemistries. Veranova is headquartered in Wayne, PA and has operations in North America and Europe.